Skip to main content

Advertisement

Table 3 League table of each treatment regimen

From: Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis

Metoclopramide       
1.32 (0.27–6.06) Trimebutine      
1.99 (0.87–4.72) 1.51 (0.38–6.74) Mosapride     
2.04 (0.92–4.60) 1.54 (0.40–6.73) 1.02 (0.64–1.65) Domperidone    
2.79 (1.29–6.21) 2.12 (0.56–9.05) 1.40 (0.92–2.14) 1.37 (1.07–1.77) Itopride   
3.07 (1.43–6.75) 2.32 (0.61–9.86) 1.53 (0.97–2.45) 1.51 (1.04–2.18) 1.10 (0.80–1.51) Itopride  
6.27 (3.03–13.48) 4.77 (1.27–19.99) 3.15 (2.09–4.74) 3.15 (2.09–4.74) 2.25 (1.78–2.85) 2.05 (1.65–2.55) Placebo
  1. Odds ratio with 95% credible interval is described in each column. Prokinetic agent in the top left means better efficacy and statistical validity is guaranteed when the 95% credible interval does not include 1